Dìlek Dìnçol

503 total citations
28 papers, 394 citations indexed

About

Dìlek Dìnçol is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Dìlek Dìnçol has authored 28 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Dìlek Dìnçol's work include Lymphoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Dìlek Dìnçol is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Dìlek Dìnçol collaborates with scholars based in Türkiye and Iran. Dìlek Dìnçol's co-authors include Fikri İçlı, Ahmet Demirkazık, Hakan Akbulut, Nazan Günel, Ahmet Demirkazık, Abdullah Büyükçelik, Bülent Yalçın, Güngör Utkan, Abdurrahman Işıkdoğan and Serpil Dızbay Sak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Dìlek Dìnçol

27 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dìlek Dìnçol Türkiye 10 143 105 79 73 58 28 394
Ahmet Demirkazık Türkiye 12 193 1.3× 222 2.1× 68 0.9× 71 1.0× 14 0.2× 29 426
GF Nash United Kingdom 6 183 1.3× 102 1.0× 25 0.3× 136 1.9× 74 1.3× 8 480
Fazıl Aydin Türkiye 11 132 0.9× 88 0.8× 54 0.7× 69 0.9× 17 0.3× 32 345
Eunyoung Lee South Korea 11 121 0.8× 49 0.5× 127 1.6× 131 1.8× 62 1.1× 30 458
José Muñoz-Langa Spain 13 271 1.9× 146 1.4× 23 0.3× 38 0.5× 33 0.6× 52 474
Josef Kovařík United Kingdom 10 169 1.2× 139 1.3× 23 0.3× 62 0.8× 38 0.7× 42 449
Georges Azzi United States 7 235 1.6× 89 0.8× 34 0.4× 88 1.2× 28 0.5× 14 403
Norma A. Hernández-Rodríguez Mexico 9 62 0.4× 314 3.0× 40 0.5× 122 1.7× 24 0.4× 12 547
Chika Shigemori Japan 5 87 0.6× 37 0.4× 24 0.3× 102 1.4× 84 1.4× 8 359
Timuçin Çil Türkiye 14 111 0.8× 119 1.1× 65 0.8× 46 0.6× 14 0.2× 62 462

Countries citing papers authored by Dìlek Dìnçol

Since Specialization
Citations

This map shows the geographic impact of Dìlek Dìnçol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dìlek Dìnçol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dìlek Dìnçol more than expected).

Fields of papers citing papers by Dìlek Dìnçol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dìlek Dìnçol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dìlek Dìnçol. The network helps show where Dìlek Dìnçol may publish in the future.

Co-authorship network of co-authors of Dìlek Dìnçol

This figure shows the co-authorship network connecting the top 25 collaborators of Dìlek Dìnçol. A scholar is included among the top collaborators of Dìlek Dìnçol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dìlek Dìnçol. Dìlek Dìnçol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eralp, Yeşim, Leyla Kılıç, Gül Alço, et al.. (2014). The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience. SHILAP Revista de lepidopterología. 10(4). 209–215. 5 indexed citations
2.
Doğan, Mutlu, Halil Gürhan Karabulut, Ajlan Tükün, et al.. (2012). Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients. Asian Pacific Journal of Cancer Prevention. 13(4). 1553–1556. 8 indexed citations
3.
Dìnçol, Dìlek, Abdullah Büyükçelik, Mutlu Doğan, et al.. (2009). Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Medical Oncology. 27(3). 942–945. 3 indexed citations
4.
5.
İçlı, Fikri, Hakan Akbulut, Güngör Utkan, et al.. (2006). Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. Journal of Surgical Oncology. 95(6). 507–512. 84 indexed citations
6.
Utkan, Güngör, Abdullah Büyükçelik, Bülent Yalçın, et al.. (2006). Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma. Lung Cancer. 53(3). 367–374. 15 indexed citations
7.
Erden, Esra, et al.. (2005). Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 447(1). 24–30. 46 indexed citations
8.
Emri, Salih, Hakan Akbulut, Faruk Zorlu, et al.. (2001). Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer. 33(2-3). 109–114. 16 indexed citations
9.
Dìnçol, Dìlek, Hakan Akbulut, Abdullah Büyükçelik, & Fikri İçlı. (2000). DIURNAL VARIATIONS OF SERUM GM-CSF LEVELS. Cytokine. 12(7). 1151–1155. 10 indexed citations
10.
Arıcan, Ali, et al.. (2000). Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Medical Oncology. 17(2). 123–126. 19 indexed citations
11.
Dìnçol, Dìlek, Ali Arıcan, Arzu Ensarı, et al.. (1999). Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney. Medical Oncology. 16(2). 134–138. 9 indexed citations
12.
Samur, Mustafa, Hakan Akbulut, Selim Erekul, et al.. (1999). The Clinical Value of Flow Cytometric DNA Content Analysis in Patientswith Soft Tissue Sarcomas. Sarcoma. 3(3-4). 171–175. 2 indexed citations
13.
İçlı, Fikri, et al.. (1999). Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil. Oncology. 56(4). 297–300. 5 indexed citations
14.
İçlı, Fikri, et al.. (1997). Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. Journal of Surgical Oncology. 64(4). 318–323. 3 indexed citations
15.
16.
İçlı, Fikri, et al.. (1996). Two dose levels of ifosfamide in malignant mesothelioma. Lung Cancer. 15(2). 207–213. 14 indexed citations
17.
18.
İçlı, Fikri, et al.. (1993). Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 72(2). 587–593. 107 indexed citations
19.
Dìnçol, Dìlek, et al.. (1992). Primary gastrointestinal lymphomas in Turkey: A retrospective analysis of clinical features and results of treatment. Journal of Surgical Oncology. 51(4). 270–273. 15 indexed citations
20.
İçlı, Fikri, et al.. (1991). Treatment of metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin. Journal of Surgical Oncology. 48(3). 199–201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmet Demirkazık Breakdown of academic impact, for papers by GF Nash Breakdown of academic impact, for papers by Fazıl Aydin Breakdown of academic impact, for papers by Eunyoung Lee Breakdown of academic impact, for papers by José Muñoz-Langa Breakdown of academic impact, for papers by Josef Kovařík Breakdown of academic impact, for papers by Georges Azzi Breakdown of academic impact, for papers by Norma A. Hernández-Rodríguez Breakdown of academic impact, for papers by Chika Shigemori Breakdown of academic impact, for papers by Timuçin Çil
Rankless by CCL
2026